Detalles de la búsqueda
1.
Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 study.
Clin Exp Rheumatol
; 37(2): 260-269, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30148436
2.
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.
J Am Acad Dermatol
; 78(4): 741-748, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29066271
3.
Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept.
J Am Acad Dermatol
; 76(4): 655-661, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28087133
4.
"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale.
Support Care Cancer
; 24(9): 3889-96, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27108262
5.
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study.
Eur J Cancer
; 183: 98-108, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36822130
6.
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day.
Cancer Med
; 12(4): 4332-4342, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464853
7.
Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer.
Int J Colorectal Dis
; 27(5): 623-34, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22076612
8.
The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial.
Lancet Rheumatol
; 4(3): e208-e219, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38288937
9.
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies.
Rheumatol Ther
; 8(1): 273-288, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33351179
10.
Quality of life in hormone receptor-positive HER-2+ metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinib.
Oncologist
; 15(9): 944-53, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20798196
11.
A case study applying a novel approach to estimate the social impact of a medical innovation - the use of secukinumab for psoriatic arthritis in Germany.
Expert Rev Pharmacoecon Outcomes Res
; 20(4): 369-378, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31322444
12.
Longitudinal Modeling Approaches to Assess the Association Between Changes in 2 Clinical Outcome Assessments.
Ther Innov Regul Sci
; 52(3): 306-312, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29714541
13.
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study.
Arthritis Care Res (Hoboken)
; 70(10): 1529-1535, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409133
14.
Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab.
J Dermatolog Treat
; 28(6): 492-499, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28266243
15.
Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score ⩾ 2.
SAGE Open Med
; 3: 2050312115613350, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27092254
16.
Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews.
Clin Ther
; 36(6): 906-17, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24863260
17.
Effect of ethnicity on weight loss among adolescents 1 year after bariatric surgery.
World J Diabetes
; 4(5): 202-9, 2013 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24147204
18.
Changes in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database.
Surg Obes Relat Dis
; 9(4): 503-13, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-22542199
19.
Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database.
J Am Coll Surg
; 214(4): 550-6; discussion 556-7, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22321517
20.
Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database.
Surg Obes Relat Dis
; 7(2): 181-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21421182